Orion Biotech Opportunities Corp Announced its IPO Earnings

Orion Biotech Opportunities Corp. announced the pricing of its initial public offering of 20,000,000 units for $10.00 per unit. The units will be listed on The Nasdaq Capital Market LLC and traded under the symbol “ORIAU” beginning May 13, 2021.

Each unit consists of one of the Orion Biotech Opportunities Corp Class A shares and one-fifth of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share for $11.50 per share. Once the securities including the units start separate trading, the Class A shares and warrants are expected to be listed on the Nasdaq under the symbols “ORIA” and “ORIAW”, respectively.

Cantor Fitzgerald & Co. is acting as the only book-running manager for the offering. The Company has awarded the underwriter a 45-day option to purchase up to 3,000,000 extra units to cover over-allotments. The offering is expected to close on May 17, 2021. It is subject to customary closing conditions. The offering is made only using a prospectus. Copies of the prospectus may be obtained, when available, from Cantor Fitzgerald & Co.

An enrollment announcement relating to these securities has been declared effective by the U.S. Securities and Exchange Commission on May 12, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful before registration or qualification under the securities laws of any such state or jurisdiction.